MIG Capital LLC Makes New Investment in Humana Inc. (NYSE:HUM)

MIG Capital LLC purchased a new stake in Humana Inc. (NYSE:HUM) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 149,163 shares of the insurance provider’s stock, valued at approximately $37,844,000. Humana accounts for about 3.9% of MIG Capital LLC’s investment portfolio, making the stock its 13th largest holding.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Columbus Hill Capital Management L.P. raised its stake in shares of Humana by 36.5% in the 4th quarter. Columbus Hill Capital Management L.P. now owns 112,622 shares of the insurance provider’s stock valued at $28,573,000 after acquiring an additional 30,132 shares during the period. Ilmarinen Mutual Pension Insurance Co lifted its stake in Humana by 46.2% during the fourth quarter. Ilmarinen Mutual Pension Insurance Co now owns 9,500 shares of the insurance provider’s stock worth $2,410,000 after purchasing an additional 3,000 shares in the last quarter. Russell Investments Group Ltd. grew its stake in shares of Humana by 43.2% in the fourth quarter. Russell Investments Group Ltd. now owns 454,072 shares of the insurance provider’s stock valued at $115,210,000 after buying an additional 137,039 shares in the last quarter. Grantham Mayo Van Otterloo & Co. LLC lifted its stake in Humana by 144.5% during the 4th quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 40,365 shares of the insurance provider’s stock worth $10,241,000 after acquiring an additional 23,853 shares in the last quarter. Finally, Rhenman & Partners Asset Management AB grew its position in Humana by 78.2% in the 4th quarter. Rhenman & Partners Asset Management AB now owns 55,230 shares of the insurance provider’s stock valued at $14,012,000 after acquiring an additional 24,230 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Down 4.6 %

HUM opened at $253.37 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The business’s 50 day moving average is $267.58 and its two-hundred day moving average is $271.85. The firm has a market cap of $30.58 billion, a price-to-earnings ratio of 25.46, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.40%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Analyst Ratings Changes

HUM has been the subject of several recent research reports. JPMorgan Chase & Co. lowered their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. StockNews.com downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th. Truist Financial lifted their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Morgan Stanley cut their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $280.17.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.